Sapience Investments’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.56K Buy
+36
New +$2.46K 0.33% 94
2025
Q3
Sell
-41,457
Closed -$1.79M 75
2025
Q2
$1.79M Sell
41,457
-1,492
-3% -$57.6K 1.19% 46
2025
Q1
$1.7M Sell
42,949
-41,580
-49% -$1.84M 1.22% 43
2024
Q4
$3.44M Sell
84,529
-15,527
-16% -$647K 2.01% 10
2024
Q3
$3.9M Buy
100,056
+26,266
+36% +$1.05M 1.93% 11
2024
Q2
$3.23M Sell
73,790
-27,340
-27% -$1.32M 1.65% 23
2024
Q1
$4.82M Sell
101,130
-53,835
-35% -$2.42M 1.6% 29
2023
Q4
$7.32M Buy
154,965
+13,230
+9% +$550K 1.74% 23
2023
Q3
$6.75M Buy
+141,735
New +$7.74M 1.62% 31

Other funds holding NGVT

Sapience Investments's NGVT Position: Q1 2026 in Review

Sapience Investments opened a new position in Ingevity (NGVT) in Q1 2026: 36 shares worth $2.56K. The stake represents 0.33% of the portfolio and ranks #94 among its holdings. This is a return to the name: Sapience Investments previously reported a position in NGVT as recently as Q2 2025.

Sapience Investments first reported a position in NGVT in Q3 2023 and has held it in 9 quarters since. The position peaked at $7.32M in Q4 2023. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Sapience Investments held 36 shares of Ingevity worth $2.56K as of Q1 2026.
  • Ingevity was a new Sapience Investments position in Q1 2026.
  • Ingevity made up 0.33% of Sapience Investments's portfolio in Q1 2026, its #94 holding.
  • Sapience Investments first reported a position in Ingevity in Q3 2023 and has held it in 9 quarters since.
  • Sapience Investments's Ingevity position peaked at $7.32M in Q4 2023.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Sapience Investments's 13F filing for Q1 2026, filed 15 May 2026.